Alisol B
Alisol B may be a potential novel therapeutic molecule for bone disorders through targeting the differentiation of osteoclasts as well as their functions. Alisol B also inhibited RANKL-induced expression of NFATc1 and c-Fos which are key transcription factors for osteoclastogenesis.
Product Specifications
CAS Number
18649-93-9
Purity
>98% (HPLC)
Solubility
DMSO:95 mg/mL (200.97 mM)
Smiles
[H][C@@]1 (OC1 (C) C) [C@@H] (O) C[C@@H] (C) C1=C2C[C@H] (O) [C@@]3 ([H]) [C@@]4 (C) CCC (=O) C (C) (C) [C@]4 ([H]) CC[C@]3 (C) [C@@]2 (C) CC1
Molecular Formula
C30H48O4
Molecular Weight
472.7
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
YVV40101 100 μg
Recombinant HAdV-7 Shutoff protein/L4 Protein, C-His
Sign In for Pricing
View Details 
EKU06049-01 48 Tests
Rat Myelin Associated Glycoprotein (MAG) ELISA Kit
Sign In for Pricing
View Details EKU06049-02 96 Tests
Rat Myelin Associated Glycoprotein (MAG) ELISA Kit
Sign In for Pricing
View Details EKU06049-03 5x 96 Tests
Rat Myelin Associated Glycoprotein (MAG) ELISA Kit
Sign In for Pricing
View Details